Noncoding RNAs involved in mammary gland development and tumorigenesis: There's a long way to go

Journal of Mammary Gland Biology and Neoplasia

Volumn 17, Issue 1, 2012, Pages 43-58

  Shore, Amy N ^a   Herschkowitz, Jason I ^a   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alveologenesis; Breast cancer; Epigenetics; Mammary gland development; Noncoding RNA

Indexed keywords

MICRORNA; SMALL UNTRANSLATED RNA; UNTRANSLATED RNA;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER GROWTH; HUMAN; MAMMAL; MAMMARY GLAND; NONHUMAN; REVIEW; RNA ANALYSIS;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; RNA, UNTRANSLATED;

EID: 84858700038     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-012-9247-3     Document Type: Review

References (135)

1. Consortium EP, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, et al. Identification and analysis of functional elements in 1%of the human genome by the ENCODE pilot project. Nature. 2007;447(7146):799-816. doi:10.1038/nature05874.
2. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, et al. Antisense transcription in the mammalian transcriptome. Science. 2005;309(5740):1564-6. doi:10.1126/ science.1112009.
3. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, et al. The transcriptional landscape of the mammalian genome. Science. 2005;309(5740):1559-63. doi:10.1126/science.1112014.
4. Bertone P, Stolc V, Royce TE, Rozowsky JS, Urban AE, Zhu X, et al. Global identification of human transcribed sequences with genome tiling arrays. Science. 2004;306(5705):2242-6. doi:10.1126/ science.1103388.
5. Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, et al. Transcriptional maps of 10 human chromosomes at 5- nucleotide resolution. Science. 2005;308(5725):1149-54. doi:10.1126/science.1108625. (Pubitemid 40696429)
6. Ravasi T, Suzuki H, Pang KC, Katayama S, Furuno M, Okunishi R, et al. Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res. 2006;16(1):11-9. doi:10.1101/gr.4200206. (Pubitemid 43048929)
7. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A. 2008;105(2):716-21. doi:10.1073/ pnas.0706729105.
8. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458 (7235):223-7. doi:10.1038/nature07672.
9. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25(18):1915-27. doi:10.1101/gad.17446611.
10. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39(6):925-38. doi:10.1016/j.molcel.2010.08.011.
11. Willingham AT, Orth AP, Batalov S, Peters EC, Wen BG, Aza- Blanc P, et al. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science. 2005;309(5740):1570-3. doi:10.1126/science.1115901. (Pubitemid 41266484)
12. Feng J, Bi C, Clark BS, Mady R, Shah P, Kohtz JD. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev. 2006;20(11):1470-84. doi:10.1101/gad.1416106. (Pubitemid 43830654)
13. Hung T,Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet. 2011;43(7):621-9. doi:10.1038/ng.848.
14. Meola N, Pizzo M, Alfano G, Surace EM, Banfi S. The long noncoding RNA Vax2os1 controls the cell cycle progression of photoreceptor progenitors in the mouse retina. RNA. 2012;18 (1):111-23. doi:10.1261/rna.029454.111.
15. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071-6. doi:10.1038/nature08975.
16. Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3(107):ra8. doi:10.1126/scisignal.2000568.
17. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009;33(6):717-26. doi:10.1016/j. molcel.2009.01.026.
18. Mazo A, Hodgson JW, Petruk S, Sedkov Y, Brock HW. Transcriptional interference: an unexpected layer of complexity in gene regulation. J Cell Sci. 2007;120(Pt 16):2755-61. doi:10.1242/ jcs.007633.
19. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358-69. doi:10.1016/j.cell.2011.09. 028.
20. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell. 1999;97(1):17-27. (Pubitemid 29165886)
21. Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V, et al. The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscledifferentiation. Dev Cell. 2006;11(4):547-60. doi:10.1016/j. devcel.2006.08.003.
22. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143(1):46-58. doi:10.1016/ j.cell.2010.09.001.
23. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106(28):11667-72. doi:10.1073/pnas.0904715106.
24. Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell. 2010;40(6):939-53. doi:10.1016/j. molcel.2010.12.011.
25. Bertani S, Sauer S, Bolotin E, Sauer F. The noncoding RNA Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin. Mol Cell. 2011;43(6):1040-6. doi:10.1016/j.molcel.2011.08. 019.
26. Dinger ME, Amaral PP, Mercer TR, Pang KC, Bruce SJ, Gardiner BB, et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008;18(9):1433-45. doi:10.1101/gr.078378.108.
27. Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatinlevel regulation. Mol Cell. 2008;32(2):232-46. doi:10.1016/j. molcel.2008.08.022.
28. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, Feil R, et al. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science. 2008;322 (5908):1717-20. doi:10.1126/science.1163802.
29. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311-23. doi:10.1016/j.cell.2007.05.022. (Pubitemid 46962090)
30. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science. 2008;322(5902):750-6. doi:10.1126/science.1163045.
31. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011;30(16):1956-62. doi:10.1038/onc.2010.568.
32. Pauli A, Rinn JL, Schier AF. Non-coding RNAs as regulators of embryogenesis. Nat Rev Genet. 2011;12(2):136-49. doi:10.1038/ nrg2904.
33. Amaral PP, Mattick JS. Noncoding RNA in development. Mamm Genome. 2008;19(7-8):454-92. doi:10.1007/s00335-008-9136-7.
34. Prasanth KV, Spector DL. Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum. Genes Dev. 2007;21(1):11-42. doi:10.1101/gad. 1484207. (Pubitemid 46089704)
35. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354-61. doi:10.1016/j. tcb.2011.04.001.
36. Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet. 2010;19(R2):R152-61. doi:10.1093/ hmg/ddq353.
37. Khalil AM, Rinn JL. RNA-protein interactions in human health and disease. Semin Cell Dev Biol. 2011;22(4):359-65. doi:10.1016/j.semcdb.2011.02.016.
38. Brockdorff N. Chromosome silencing mechanisms in Xchromosome inactivation: unknown unknowns. Development. 2011;138(23):5057-65. doi:10.1242/dev.065276.
39. Lee JT. Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control. Nat Rev Mol Cell Biol. 2011;12(12):815-26. doi:10.1038/nrm3231.
40. Bartolomei MS, Ferguson-Smith AC. Mammalian genomic imprinting. Cold Spring Harb Perspect Biol. 2011;3:7. doi:10.1101/ cshperspect.a002592.
41. Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477(7364):295-300. doi:10.1038/nature10398.
42. Sheik Mohamed J, Gaughwin PM, Lim B, Robson P, Lipovich L. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA. 2010;16(2):324-37. doi:10.1261/rna.1441510.
43. Wagner LA, Christensen CJ, Dunn DM, Spangrude GJ, Georgelas A, Kelley L, et al. EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. Blood. 2007;109 (12):5191-8. doi:10.1182/blood-2006-06- 027987. (Pubitemid 46890536)
44. Zhang X, Lian Z, Padden C, Gerstein MB, Rozowsky J, Snyder M, et al. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood. 2009;113(11):2526-34. doi:10.1182/blood-2008-06- 162164.
45. Hu W, Yuan B, Flygare J, Lodish HF. Long noncoding RNAmediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev. 2011;25(24):2573-8. doi:10.1101/ gad.178780.111.
46. Ponjavic J, Oliver PL, Lunter G, Ponting CP. Genomic and transcriptional co-localization of protein-coding and long noncoding RNA pairs in the developing brain. PLoS Genet. 2009;5 (8):e1000617. doi:10.1371/journal.pgen.1000617.
47. Ng SY, Johnson R, Stanton LW. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 2012;31(3):522-33. doi:10.1038/emboj.2011.459.
48. Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res. 2010;1338:20-35. doi:10.1016/j.brainres.2010. 03.110.
49. Bond AM, Vangompel MJ, Sametsky EA, Clark MF, Savage JC, Disterhoft JF, et al. Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat Neurosci. 2009;12(8):1020-7. doi:10.1038/nn.2371.
50. Young TL, Matsuda T, Cepko CL. The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol. 2005;15(6):501-12. doi:10.1016/j. cub.2005.02.027.
51. Rapicavoli NA, Poth EM, Blackshaw S. The long noncoding RNA RNCR2 directs mouse retinal cell specification. BMC Dev Biol. 2010;10:49. doi:10.1186/1471-213X-10-49.
52. Kretz M, Webster DE, Flockhart RJ, Lee CS, Zehnder A, Lopez- Pajares V, et al. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev. 2012. doi:10.1101/ gad.182121.111.
53. Watson CJ, Khaled WT. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development. 2008;135(6):995-1003. doi:10.1242/dev.005439. (Pubitemid 351578128)
54. Anderson SM, Rudolph MC, McManaman JL, Neville MC. Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis! Breast Cancer Res. 2007;9(1):204. doi:10.1186/bcr1653.
55. Brisken C, Rajaram RD. Alveolar and lactogenic differentiation. J Mammary Gland Biol Neoplasia. 2006;11(3-4):239-48. doi:10.1007/s10911-006-9026-0. (Pubitemid 44869919)
56. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009;23(22):2563-77. doi:10.1101/gad.1849509.
57. Oakes SR, Hilton HN, Ormandy CJ. The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Res. 2006;8(2):207. doi:10.1186/bcr1411.
58. Hennighausen L, Robinson GW. Information networks in the mammary gland. Nat Rev Mol Cell Biol. 2005;6(9):715-25. doi:10.1038/nrm1714. (Pubitemid 41742795)
59. Siegel PM, Muller WJ. Transcription factor regulatory networks in mammary epithelial development and tumorigenesis. Oncogene. 2010;29(19):2753-9. doi:10.1038/onc.2010.43.
60. Adriaenssens E, Lottin S, Duqimont T, Fauquette W, Coll J, Dupouy JP, Boilly B, Curgy JJ. Steroid hormones modulate H19 gene expression in both mammary gland and uterus. Oncogene. 1999;18(31):4460-73. (Pubitemid 29396654)
61. Lanz RB, Chua SS, Barron N, Soder BM, DeMayo F, O'Malley BW. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol. 2003;23(20):7163-76. (Pubitemid 37210999)
62. Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, et al. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. 2011;17(5):878-91. doi:10.1261/rna. 2528811.
63. GingerMR, Shore AN, Contreras A, Rijnkels M,Miller J, Gonzalez- Rimbau MF, et al. A noncoding RNA is a potential marker of cell fate duringmammary gland development. Proc Natl Acad Sci US A. 2006;103(15):5781-6. doi:10.1073/pnas.0600745103.
64. Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol. 2001;15(11):1993-2009. (Pubitemid 33022536)
65. Guan LS, Rauchman M, Wang ZY. Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition. J Biol Chem. 1998;273(42):27047-50. (Pubitemid 28500406)
66. Tursun B, Patel T, Kratsios P, Hobert O. Direct conversion of C. elegans germ cells into specific neuron types. Science. 2011;331 (6015):304-8. doi:10.1126/science.1199082.
67. Anderson AE, Karandikar UC, Pepple KL, Chen Z, Bergmann A, Mardon G. The enhancer of trithorax and polycomb gene Caf1/p55 is essential for cell survival and patterning in Drosophila development. Development. 2011;138(10):1957-66. doi:10.1242/ dev.058461.
68. Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 2002;16(22):2893-905. doi:10.1101/gad.1035902. (Pubitemid 35334738)
69. Vorbach C, Capecchi MR, Penninger JM. Evolution of the mammary gland from the innate immune system? Bioessays. 2006;28 (6):606-16. doi:10.1002/bies. 20423. (Pubitemid 43886186)
70. Rijnkels M, Kabotyanski E, Montazer-Torbati MB, Hue Beauvais C, Vassetzky Y, Rosen JM, et al. The epigenetic landscape of mammary gland development and functional differentiation. J Mammary Gland Biol Neoplasia. 2010;15(1):85-100. doi:10.1007/ s10911-010-9170-4.
71. Lemay DG, Lynn DJ, Martin WF, Neville MC, Casey TM, Rincon G, et al. The bovine lactation genome: insights into the evolution of mammalian milk. Genome Biol. 2009;10(4):R43. doi:10.1186/gb-2009-10-4-r43.
72. Takeda K, Ichijo H, Fujii M, Mochida Y, Saitoh M, Nishitoh H, et al. Identification of a novel bone morphogenetic proteinresponsive gene that may function as a noncoding RNA. J Biol Chem. 1998;273(27):17079-85. (Pubitemid 28311742)
73. Yochum GS, Cleland R, McWeeney S, Goodman RH. An antisense transcript induced by Wnt/beta-catenin signaling decreases E2F4. J Biol Chem. 2007;282(2):871-8. doi:10.1074/jbc. M609391200.
74. Kohtz JD, Fishell G. Developmental regulation of EVF-1, a novel non-coding RNA transcribed upstream of the mouse Dlx6 gene. Gene Expr Patterns. 2004;4(4):407-12. doi:10.1016/j.modgep. 2004.01.007.
75. Tsutsumi M, Itoh M. Novel transcript nort is a downstream target gene of the Notch signaling pathway in zebrafish. Gene Expr Patterns. 2007;7(3):227-32. doi:10.1016/j.modgep.2006.10.002. (Pubitemid 44835285)
76. Gibb EA,Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY, et al. Human cancer long non-coding RNA transcriptomes. PLoS One. 2011;6(10):e25915. doi:10.1371/journal.pone.0025915.
77. Maruyama R, ShipitsinM, Choudhury S,Wu Z, Protopopov A, Yao J, et al. Altered antisense-to-sense transcript ratios in breast cancer. Proc Natl Acad Sci U S A. 2010. doi:10.1073/pnas.1010559107.
78. Perez DS, Hoage TR, Pritchett JR, Ducharme-Smith AL, Halling ML, Ganapathiraju SC, et al. Long, abundantly expressed noncoding transcripts are altered in cancer. Hum Mol Genet. 2008;17 (5):642-55. doi:10.1093/hmg/ddm336. (Pubitemid 351292254)
79. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869-74. doi:10.1073/pnas.191367098. (Pubitemid 32878711)
80. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100 (14):8418-23. doi:10.1073/pnas. 0932692100. (Pubitemid 36842560)
81. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007;8(10):R214. doi:10.1186/gb-2007-8-10-r214.
82. Wilusz JE, Freier SM, Spector DL. 3′ end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell. 2008;135(5):919-32. doi:10.1016/j.cell.2008.10.012.
83. Yang L, Lin C, Liu W, Zhang J, Ohgi KA, Grinstein JD, et al. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell. 2011;147(4):773-88. doi:10.1016/j.cell.2011.08. 054.
84. Adriaenssens E, Dumont L, Lottin S, Bolle D, Lepretre A, Delobelle A, et al. H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am J Pathol. 1998;153(5):1597-607. doi:10.1016/S0002-9440(10)65748- 3. (Pubitemid 28509917)
85. Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays. 2010;32(6):473-80. doi:10.1002/bies.200900170.
86. Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2005;280(33):29625-36. doi:10.1074/jbc.M504033200. (Pubitemid 41177038)
87. Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-Lail R, Fellig Y, et al. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta. 2010;1803(4):443-51. doi:10.1016/j.bbamcr.2010.01.010.
88. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007;67(8):3963-9. doi:10.1158/0008-5472.CAN-06-2004. (Pubitemid 46762186)
89. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010;38(5):662-74. doi:10.1016/j.molcel.2010.03.021.
90. Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011;25(2):444-8. doi:10.1096/fj.10-172452.
91. Wang X, Arai S, Song X, Reichart D, Du K, Pascual G, et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature. 2008;454(7200):126-30. doi:10.1038/nature06992. (Pubitemid 351934270)
92. Silva JM, Boczek NJ, Berres MW, Ma X, Smith DI. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8(3):496-505.
93. Chen W, Bocker W, Brosius J, Tiedge H. Expression of neural BC200 RNA in human tumours. J Pathol. 1997;183(3):345-51. doi:10.1002/(SICI)1096-9896(199711) 183:3〈345::AIDPATH930〉 3.0.CO;2-8.
94. Iacoangeli A, Lin Y, Morley EJ, Muslimov IA, Bianchi R, Reilly J, et al. BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis. 2004;25(11):2125-33. doi:10.1093/carcin/bgh228. (Pubitemid 39534849)
95. Candeias MM, Malbert-Colas L, Powell DJ, Daskalogianni C, Maslon MM, Naski N, et al. P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol. 2008;10(9):1098-105. doi:10.1038/ncb1770.
96. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature. 2009;460(7254):529-33. doi:10.1038/nature08199.
97. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447(7148):1130-4. doi:10.1038/nature05939. (Pubitemid 47014436)
98. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol. 2011;13 (3):317-23. doi:10.1038/ncb2173.
99. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, et al. p53 regulates epithelial-mesenchymal transition through micro- RNAs targeting ZEB1 and ZEB2. J Exp Med. 2011;208(5):875-83. doi:10.1084/jem.20110235.
100. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142(3):409-19. doi:10.1016/j.cell. 2010.06.040.
101. Zhou Y, Zhong Y,Wang Y, Zhang X, Batista DL, Gejman R, et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007;282(34):24731-42. doi:10.1074/jbc.M702029200. (Pubitemid 47347547)
102. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, et al. microRNA-29 can regulate expression of the long noncoding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011;30(47):4750-6. doi:10.1038/onc.2011.193.
103. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010;70(6):2350-8. doi:10.1158/0008-5472.CAN-09-3885.
104. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88(11):5119-26. (Pubitemid 37452705)
105. Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M, et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res. 2010;34(2):148-53. doi:10.1016/j.leukres.2009.06.019.
106. Gibb EA, Brown CJ, Lam WL. The functional role of long noncoding RNA in human carcinomas. Mol Cancer. 2011;10:38. doi:10.1186/1476-4598-10-38.
107. Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, Lis JT, et al. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell. 2011;145(4):622-34. doi:10.1016/j.cell.2011.03.042.
108. Schwartz JC, Younger ST, Nguyen NB, Hardy DB, Monia BP, Corey DR, et al. Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol. 2008;15(8):842-8. doi:10.1038/ nsmb.1444.
109. Younger ST, Corey DR. Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res. 2011;39(13):5682-91. doi:10.1093/nar/gkr155.
110. Leygue E, Dotzlaw H, Watson PH, Murphy LC. Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res. 1999;59(17):4190-3. (Pubitemid 29418723)
111. Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, et al. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the Nterminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J. 2001;20(6):1341-52. doi:10.1093/emboj/ 20.6.1341.
112. Hube F, Guo J, Chooniedass-Kothari S, Cooper C, Hamedani MK, Dibrov AA, et al. Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol. 2006;25(7):418-28. doi:10.1089/dna.2006.25.418. (Pubitemid 44175334)
113. Cooper C, Guo J, Yan Y, Chooniedass-Kothari S, Hube F, Hamedani MK, et al. Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res. 2009;37(13):4518-31. doi:10.1093/nar/ gkp441.
114. Foulds CE, Tsimelzon A, Long W, Le A, Tsai SY, Tsai MJ, et al. Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. Mol Endocrinol. 2010;24(5):1090-105. doi:10.1210/ me.2009-0427.
115. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28 (2):195-208. doi:10.1038/onc.2008.373.
116. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, Taylor M, et al. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer. 2011;104(7):1168-77. doi:10.1038/sj.bjc.6606076.
117. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329(5992):689-93. doi:10.1126/science.1192002.
118. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. Genomic maps of long noncoding RNA occupancy reveal principles of RNAchromatin interactions. Mol Cell. 2011;44(4):667-78. doi:10.1016/j.molcel.2011.08.027.
119. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. CREB upregulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38(16):5366-83. doi:10.1093/nar/gkq285.
120. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465 (7301):1033-8. doi:10.1038/nature09144.
121. Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG, et al. In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell. 2011;147(2):382-95. doi:10.1016/j.cell.2011.09. 032.
122. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell. 2011;147(2):344-57. doi:10.1016/j.cell.2011.09.029.
123. Hansen TB, Wiklund ED, Bramsen JB, Villadsen SB, Statham AL, Clark SJ, et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 2011;30(21):4414-22. doi:10.1038/emboj.2011.359.
124. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007;12 (3):215-29. doi:10.1016/j.ccr.2007.07.027. (Pubitemid 47333418)
125. Jin G, Sun J, Isaacs SD, Wiley KE, Kim ST, Chu LW, et al. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis. 2011;32 (11):1655-9. doi:10.1093/carcin/bgr187.
126. Yang R, Frank B, Hemminki K, Bartram CR, Wappenschmidt B, Sutter C, et al. SNPs in ultraconserved elements and familial breast cancer risk. Carcinogenesis. 2008;29(2):351-5. doi:10.1093/carcin/ bgm290.
127. Day JR, Jost M, Reynolds MA, Groskopf J, Rittenhouse H. PCA3: from basic molecular science to the clinical lab. Cancer Lett. 2011;301(1):1-6. doi:10.1016/j.canlet.2010.10.019.
128. Lee GL, Dobi A, Srivastava S. Prostate cancer: diagnostic performance of the PCA3 urine test. Nat Rev Urol. 2011;8(3):123-4. doi:10.1038/nrurol.2011.10.
129. BussemakersMJ, van BokhovenA,VerhaeghGW, Smit FP,Karthaus HF, Schalken JA, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999;59(23):5975-9. (Pubitemid 30004960)
130. Moskalev EA, Schubert M, Hoheisel JD. RNA-directed epigenomic reprogramming: an emerging principle of a more targeted cancer therapy? Genes Chromosomes Cancer. 2012;51(2):105-10. doi:10.1002/gcc.20943.
131. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011;71 (1):3-7. doi:10.1158/0008-5472.CAN- 10-2483.
132. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010;42(2):181-5. doi:10.1038/ng.518.
133. Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, et al. The genetic landscape of the childhood cancer medulloblastoma. Science. 2011;331(6016):435- 9. doi:10.1126/science.1198056.
134. Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331(6021):1199-203. doi:10.1126/science. 1200609.
135. Rotblat B, Leprivier G, Sorensen PH. A possible role for long non-coding RNA in modulating signaling pathways. Med Hypotheses. 2011;77(6):962-5. doi:10.1016/j.mehy.2011.08.020.